Atlas Trials

A Performance and Bioavailability Study of Entrectinib in Healthy Volunteers.

Clinical trial NCT03961100 · COMPLETED

Trial details

NCT number
NCT03961100
Sponsor
Genentech, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumor
Start date
2019-06-06
Primary completion
2019-08-09
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.